Cargando…

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series

SCN8A‐developmental and epileptic encephalopathy is caused by pathogenic variants in the SCN8A gene encoding the Na(v)1.6 sodium channel, and is characterized by intractable multivariate seizures and developmental regression. Fenfluramine is a repurposed drug with proven antiseizure efficacy in Drav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aledo‐Serrano, Ángel, Cabal‐Paz, Borja, Gardella, Elena, Gómez‐Porro, Pablo, Martínez‐Múgica, Otilia, Beltrán‐Corbellini, Alvaro, Toledano, Rafael, García‐Morales, Irene, Gil‐Nagel, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436303/ https://www.ncbi.nlm.nih.gov/pubmed/35802036 http://dx.doi.org/10.1002/epi4.12623

Ejemplares similares

Epilepsy Genetics and Precision Medicine in Adults: A New Landscape for Developmental and Epileptic Encephalopathies
por: Beltrán-Corbellini, Álvaro, et al.
Publicado: (2022)

Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017)

Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures
por: Wang, Jiaping, et al.
Publicado: (2017)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

Recurrent and Non-Recurrent Mutations of SCN8A in Epileptic Encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy
por: Wagnon, Jacy L., et al.
Publicado: (2015)

Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy
por: Kambouris, Marios, et al.
Publicado: (2016)

SCN1B‐linked early infantile developmental and epileptic encephalopathy
por: Aeby, Alec, et al.
Publicado: (2019)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

SCN8A Mutation in Infantile Epileptic Encephalopathy: Report of Two Cases
por: Fatema, Kanij, et al.
Publicado: (2019)

Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy
por: Thompson, Jeremy A., et al.
Publicado: (2022)

Case Series of Early SCN1A-Related Developmental and Epileptic Encephalopathies
por: Gowda, Vykuntaraju Kammasandra, et al.
Publicado: (2021)

Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy
por: Miao, Pu, et al.
Publicado: (2020)

Ketogenic Diet in Infants with Early-Onset Epileptic Encephalopathy and SCN2A Mutation
por: Tian, Xiaoyu, et al.
Publicado: (2021)

Persistent sodium currents in SCN1A developmental and degenerative epileptic dyskinetic encephalopathy
por: Gorman, Kathleen M, et al.
Publicado: (2021)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

De novo variants in the alternative exon 5 of SCN8A cause epileptic encephalopathy
Publicado: (2018)

Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants
por: Thompson, Christopher H., et al.
Publicado: (2020)

Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy
por: Asinof, Samuel K., et al.
Publicado: (2015)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

Brain Inflammation in an Infant With Hemimegalencephaly, Escalating Seizures, and Epileptic Encephalopathy
por: Kim, Se Hee, et al.
Publicado: (2016)

A Complex Genomic Rearrangement Resulting in Loss of Function of SCN1A and SCN2A in a Patient with Severe Developmental and Epileptic Encephalopathy
por: Orlando, Valeria, et al.
Publicado: (2022)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
por: Sullivan, Joseph, et al.
Publicado: (2021)

Duration of epileptic seizure types: A data‐driven approach
por: Meritam Larsen, Pirgit, et al.
Publicado: (2023)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype
por: Sadleir, Lynette G., et al.
Publicado: (2017)

Biallelic SCN2A Gene Mutation Causing Early Infantile Epileptic Encephalopathy: Case Report and Review
por: AlSaif, Shahad, et al.
Publicado: (2019)

Beyond Dravet Syndrome: Characterization of a Novel, More Severe SCN1A-Linked Epileptic Encephalopathy
por: Beck, Veronica C., et al.
Publicado: (2019)

Epileptic Encephalopathy
por: Specchio, Nicola, et al.
Publicado: (2012)

Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy
por: Merseburg, Andrea, et al.
Publicado: (2022)

Re-annotation of 191 developmental and epileptic encephalopathy-associated genes unmasks de novo variants in SCN1A
por: Steward, Charles A., et al.
Publicado: (2019)

A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: a case report
por: Lin, Kao-Min, et al.
Publicado: (2019)

Impact of comorbid psychogenic non-epileptic seizures on migraine: An observational study
por: Uniyal, Ravi, et al.
Publicado: (2023)

Adrenergic Mechanisms of Audiogenic Seizure-Induced Death in a Mouse Model of SCN8A Encephalopathy
por: Wengert, Eric R., et al.
Publicado: (2021)

Epileptic seizures
por: Anwar, Haleema, et al.
Publicado: (2020)

De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy
por: Stringer, Robin N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6q06ma246aeib8dr3u28dcmu1j